Paromomycin affects translation and vesicle-mediated trafficking as revealed by proteomics of paromomycin -susceptible -resistant leishmania donovani

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Chawla, Bhavna ^a   Jhingran, Anupam ^a   Panigrahi, Aswini ^b   Stuart, Kenneth D ^b   Madhubala, Rentala ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b Seattle BioMed   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLYCOLYTIC ENZYME; HEAT SHOCK PROTEIN; PAROMOMYCIN; RIBOSOME PROTEIN; ANTIPROTOZOAL AGENT; PROTOZOAL PROTEIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CELL CULTURE; CELL ULTRASTRUCTURE; CELL VACUOLE; CONTROLLED STUDY; DOWN REGULATION; ELECTRON MICROSCOPY; ISOTOPE LABELING; LEISHMANIA DONOVANI; MASS SPECTROMETRY; NONHUMAN; PARASITE IDENTIFICATION; PARASITE SURVIVAL; PARASITE VIRULENCE; PROTEIN ANALYSIS; PROTEIN TRANSPORT; PROTEOMICS; QUANTITATIVE ANALYSIS; RNA TRANSLATION; UPREGULATION; WILD TYPE; DRUG EFFECT; DRUG RESISTANCE; GENETICS; METHODOLOGY; PROTEIN SYNTHESIS;

LEISHMANIA DONOVANI; PROTOZOA;

ANTIPROTOZOAL AGENTS; DRUG RESISTANCE; LEISHMANIA DONOVANI; PAROMOMYCIN; PROTEIN BIOSYNTHESIS; PROTEIN TRANSPORT; PROTEOMICS; PROTOZOAN PROTEINS;

EID: 80055037796     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026660     Document Type: Article

References (50)

1. Davis BD, (1987) Mechanism of bactericidal action of aminoglycosides. Microbiol Rev 51: 341-350.
2. Gillin FD, Diamond LS, (1981) Inhibition of clonal growth of Giardia lamblia and Entamoeba histolytica by metronidazole, quinacrine, and other antimicrobial agents. J Antimicrob Chemother 8: 305-316.
3. Flanigan TP, Ramratnam B, Graeber C, Hellinger J, Smith D, et al. (1996) Prospective trial of paromomycin for cryptosporidiosis in AIDS. Am J Med 100: 370-372 S0002-9343(97)89499-5 [pii];10.1016/S0002-9343(97)89499-5 [doi].
4. Hirokawa G, Kaji H, Kaji A, (2007) Inhibition of antiassociation activity of translation initiation factor 3 by paromomycin. Antimicrob Agents Chemother 51: 175-180 AAC.01096-06 [pii];10.1128/AAC.01096-06 [doi].
5. Fourmy D, Recht MI, Blanchard SC, Puglisi JD, (1996) Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic. Science 274: 1367-1371.
6. Khalil EA, el Hassan AM, Zijlstra EE, Hashim FA, Ibrahim ME, et al. (1998) Treatment of visceral leishmaniasis with sodium stibogluconate in Sudan: management of those who do not respond. Ann Trop Med Parasitol 92: 151-158.
7. Sundar S, More DK, Singh MK, Singh VP, Sharma S, et al. (2000) Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis 31: 1104-1107 CID000236 [pii];10.1086/318121 [doi].
8. Lira R, Sundar S, Makharia A, Kenney R, Gam A, et al. (1999) Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J Infect Dis 180: 564-567 JID981498 [pii];10.1086/314896 [doi].
9. Armijos RX, Weigel MM, Calvopina M, Mancheno M, Rodriguez R, (2004) Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis. Acta Trop 91: 153-160 10.1016/j.actatropica.2004.03.009 [doi];S0001706X04000713 [pii].
10. Thakur CP, Kanyok TP, Pandey AK, Sinha GP, Messick C, et al. (2000) Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study. Trans R Soc Trop Med Hyg 94: 432-433.
11. Sundar S, Jha TK, Thakur CP, Sinha PK, Bhattacharya SK, (2007) Injectable paromomycin for Visceral leishmaniasis in India. N Engl J Med 356: 2571-2581 356/25/2571 [pii];10.1056/NEJMoa066536 [doi].
12. el-On J, Halevy S, Grunwald MH, Weinrauch L, (1992) Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study. J Am Acad Dermatol 27: 227-231.
13. Scott JA, Davidson RN, Moody AH, Grant HR, Felmingham D et al, (1992) Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom. Trans R Soc Trop Med Hyg 86: 617-619.
14. Maarouf M, de KY, Brown S, Petit PX, Robert-Gero M, (1997) In vivo interference of paromomycin with mitochondrial activity of Leishmania. Exp Cell Res 232: 339-348 S0014-4827(97)93500-X [pii];10.1006/excr.1997.3500 [doi].
15. Jhingran A, Chawla B, Saxena S, Barrett MP, Madhubala R, (2009) Paromomycin: uptake and resistance in Leishmania donovani. Mol Biochem Parasitol 164: 111-117 S0166-6851(08)00287-9 [pii];10.1016/j.molbiopara.2008.12.007 [doi].
16. Fernandez MM, Malchiodi EL, Algranati ID, (2011) Differential effects of paromomycin on ribosomes of Leishmania mexicana and mammalian cells. Antimicrob Agents Chemother 55: 86-93 AAC.00506-10 [pii];10.1128/AAC.00506-10 [doi].
17. Rosenzweig D, Smith D, Opperdoes F, Stern S, Olafson RW, et al. (2008) Retooling Leishmania metabolism: from sand fly gut to human macrophage. FASEB J 22: 590-602 fj.07-9254com [pii];10.1096/fj.07-9254com [doi].
18. Drummelsmith J, Brochu V, Girard I, Messier N, Ouellette M, (2003) Proteome mapping of the protozoan parasite Leishmania and application to the study of drug targets and resistance mechanisms. Mol Cell Proteomics 2: 146-155 10.1074/mcp.M200085-MCP200 [doi];M200085-MCP200 [pii].
19. Walker J, Acestor N, Gongora R, Quadroni M, Segura I, et al. (2006) Comparative protein profiling identifies elongation factor-1beta and tryparedoxin peroxidase as factors associated with metastasis in Leishmania guyanensis. Mol Biochem Parasitol 145: 254-264 S0166-6851(05)00304-X [pii];10.1016/j.molbiopara.2005.10.008 [doi].
20. Dea-Ayuela MA, Rama-Iniguez S, Bolas-Fernandez F, (2006) Proteomic analysis of antigens from Leishmania infantum promastigotes. Proteomics 6: 4187-4194 10.1002/pmic.200600101 [doi].
21. Vergnes B, Gourbal B, Girard I, Sundar S, Drummelsmith J, et al. (2007) A proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death. Mol Cell Proteomics 6: 88-101 M600319-MCP200 [pii];10.1074/mcp.M600319-MCP200 [doi].
22. van Weelden SW, van Hellemond JJ, Opperdoes FR, Tielens AG, (2005) New functions for parts of the Krebs cycle in procyclic Trypanosoma brucei, a cycle not operating as a cycle. J Biol Chem 280: 12451-12460 M412447200 [pii];10.1074/jbc.M412447200 [doi].
23. Vila-Sanjurjo A, Squires CL, Dahlberg AE, (1999) Isolation of kasugamycin resistant mutants in the 16 S ribosomal RNA of Escherichia coli. J Mol Biol 293: 1-8 10.1006/jmbi.1999.3160 [doi];S0022-2836(99)93160-1 [pii].
24. Kramer DL, Black JD, Mett H, Bergeron RJ, Porter CW, (1998) Lysosomal sequestration of polyamine analogues in Chinese hamster ovary cells resistant to the S-adenosylmethionine decarboxylase inhibitor, CGP-48664. Cancer Res 58: 3883-3890.
25. Shapiro AB, Fox K, Lee P, Yang YD, Ling V, (1998) Functional intracellular P-glycoprotein. Int J Cancer 76: 857-864 10.1002/(SICI)1097-0215(19980610)76:6&857::AID-IJC15>3.0.CO;2-# [pii].
26. Sognier MA, Zhang Y, Eberle RL, Sweet KM, Altenberg GA, et al. (1994) Sequestration of doxorubicin in vesicles in a multidrug-resistant cell line (LZ-100). Biochem Pharmacol 48: 391-401.
27. Legare D, Richard D, Mukhopadhyay R, Stierhof YD, Rosen BP, et al. (2001) The Leishmania ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase. J Biol Chem 276: 26301-26307 10.1074/jbc.M102351200 [doi];M102351200 [pii].
28. Jain R, Ghoshal A, Mandal C, Shaha C, (2010) Leishmania cell surface prohibitin: role in host-parasite interaction. Cell Microbiol 12: 432-452 CMI1406 [pii];10.1111/j.1462-5822.2009.01406.x [doi].
29. Welburn SC, Murphy NB, (1998) Prohibitin and RACK homologues are up-regulated in trypanosomes induced to undergo apoptosis and in naturally occurring terminally differentiated forms. Cell Death Differ 5: 615-622 10.1038/sj.cdd.4400393 [doi].
30. Dougherty MK, Morrison DK, (2004) Unlocking the code of 14-3-3. J Cell Sci 117: 1875-1884 10.1242/jcs.01171 [doi];117/10/1875 [pii].
31. Brochu C, Haimeur A, Ouellette M, (2004) The heat shock protein HSP70 and heat shock cognate protein HSC70 contribute to antimony tolerance in the protozoan parasite leishmania. Cell Stress Chaperones 9: 294-303.
32. Wu M, Tan HM, (1994) The Saccharomyces cerevisiae homologue of ribosomal protein S26. Gene 150: 401-402 0378-1119(94)90461-8 [pii].
33. Li R, Liu XL, Du QF, Zhang S, Luo RC, et al. (2004) [Proteome analysis of apoptotic K562 cells induced by harringtonine]. Zhonghua Xue Ye Xue Za Zhi 25: 323-327.
34. Kusumawidjaja G, Kayed H, Giese N, Bauer A, Erkan M, et al. (2007) Basic transcription factor 3 (BTF3) regulates transcription of tumor-associated genes in pancreatic cancer cells. Cancer Biol Ther 6: 367-376 3704 [pii].
35. Brockstedt E, Otto A, Rickers A, Bommert K, Wittmann-Liebold B, (1999) Preparative high-resolution two-dimensional electrophoresis enables the identification of RNA polymerase B transcription factor 3 as an apoptosis-associated protein in the human BL60-2 Burkitt lymphoma cell line. J Protein Chem 18: 225-231.
36. Amin MA, Matsunaga S, Ma N, Takata H, Yokoyama M, et al. (2007) Fibrillarin, a nucleolar protein, is required for normal nuclear morphology and cellular growth in HeLa cells. Biochem Biophys Res Commun 360: 320-326 S0006-291X(07)01235-1 [pii];10.1016/j.bbrc.2007.06.092 [doi].
37. Jansen RP, Hurt EC, Kern H, Lehtonen H, Carmo-Fonseca M, et al. (1991) Evolutionary conservation of the human nucleolar protein fibrillarin and its functional expression in yeast. J Cell Biol 113: 715-729.
38. Barth S, Shalem B, Hury A, Tkacz ID, Liang XH, et al. (2008) Elucidating the role of C/D snoRNA in rRNA processing and modification in Trypanosoma brucei. Eukaryot Cell 7: 86-101 EC.00215-07 [pii];10.1128/EC.00215-07 [doi].
39. Tollervey D, Lehtonen H, Jansen R, Kern H, Hurt EC, (1993) Temperature-sensitive mutations demonstrate roles for yeast fibrillarin in pre-rRNA processing, pre-rRNA methylation, and ribosome assembly. Cell 72: 443-457 0092-8674(93)90120-F [pii].
40. de SW, Souto-Padron T, (1980) The paraxial structure of the flagellum of trypanosomatidae. J Parasitol 66: 229-236.
41. Overath P, Stierhof YD, Wiese M, (1997) Endocytosis and secretion in trypanosomatid parasites- Tumultuous traffic in a pocket. Trends Cell Biol 7: 27-33 S0962-8924(97)10046-0 [pii];10.1016/S0962-8924(97)10046-0 [doi].
42. Vieira M, Rohloff P, Luo S, Cunha-e-Silva NL, de SW, et al. (2005) Role for a P-type H+-ATPase in the acidification of the endocytic pathway of Trypanosoma cruzi. Biochem J 392: 467-474 BJ20051319 [pii];10.1042/BJ20051319 [doi].
43. Magnet S, Blanchard JS, (2005) Molecular insights into aminoglycoside action and resistance. Chem Rev 105: 477-498 10.1021/cr0301088 [doi].
44. Guha-Niyogi A, Sullivan DR, Turco SJ, (2001) Glycoconjugate structures of parasitic protozoa. Glycobiology 11: 45R-59R.
45. Ilgoutz SC, McConville MJ, (2001) Function and assembly of the Leishmania surface coat. Int J Parasitol 31: 899-908 S0020-7519(01)00197-7 [pii].
46. Zheng Z, Tweten RK, Mensa-Wilmot K, (2005) Intracellular glycosylphosphatidylinositols accumulate on endosomes: toxicity of alpha-toxin to Leishmania major. Eukaryot Cell 4: 556-566 4/3/556 [pii];10.1128/EC.4.3.556-566.2005 [doi].
47. Glaser TA, Baatz JE, Kreishman GP, Mukkada AJ, (1988) pH homeostasis in Leishmania donovani amastigotes and promastigotes. Proc Natl Acad Sci U S A 85: 7602-7606.
48. Maarouf M, Lawrence F, Croft SL, Robert-Gero M, (1995) Ribosomes of Leishmania are a target for the aminoglycosides. Parasitol Res 81: 421-425.
49. Descoteaux A, Avila HA, Zhang K, Turco SJ, Beverley SM, (2002) Leishmania LPG3 encodes a GRP94 homolog required for phosphoglycan synthesis implicated in parasite virulence but not viability. EMBO J 21: 4458-4469.
50. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254 S0003269776699996 [pii].